Position in NNVC
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$13,800
+$4,700 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 48 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NNVC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRUE Private Wealth Advisors holds $224,413 across 2 Biotechnology names. NNVC ranks #2 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
424 | $210,613 | |
| 2 | NNVC |
Nanoviricides, Inc.
This page
|
10,000 | $13,800 |
All Filings in NNVC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,800 | 10,000 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $9,100 | 10,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,300 | 10,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,300 | 10,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||